During the past decade, Hopital Lapeyronie conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 14 clinical trials were completed, i.e. on average, 19.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Lapeyronie" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 28 trials, followed by "University Hospital, Montpellier" with 17 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Lapeyronie" #1 collaborator was "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "Université Montpellier" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator and "RCTs" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Lapeyronie" are "Rheumatoid Arthritis" (10 trials), "Systemic Lupus Erythematosus" (4 trials), "Type 1 Diabetes" (4 trials), "Arthritis, Rheumatoid" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "Hopital Lapeyronie" in a lesser frequency.

Most popular intervention types in "Hopital Lapeyronie" are "Drug" (43 trials), "Other" (25 trials), "Device" (16 trials), "Biological" (14 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ixekizumab" (2 trials), "MabThera" (2 trials), "10 days of intravenous placebo (isotonic saline)" (1 trials) and "1st perfusion of ketamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Lapeyronie" are 99 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 25 active trials in "Hopital Lapeyronie". 1 are not yet recruiting, 17 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 67 completed trials in Hopital Lapeyronie, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Lapeyronie, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 35 trials that are defined as “Not Applicable".